In addition, in 2022, they reported that there are many protein-coding genes whose expression was affected by 25 μM PNLA treatment of purified CD14 monocytes from patients with RA stimulated with 0.1 μg/mL of LPS as shown in Table 4. The gene discussed is CD14; the disease is rheumatoid arthritis.